University Awards
Recognising Excellence
  • Monoclonal antibodies
  • Mycobacterium Tuberculosis
  • Virus Immunology
  • Addressed a decade-old challenge in quantum complexity theory by showing that quantum interactive proofs do not have extra power over classical interactive proofs, and that quantum verification efficiently in time equates classical solution efficiently in space
  • Established that an important class QIP (the class of decision problems solved by an efficient quantum verifier using interaction with an all powerful prover) is contained in PSPACE (the class of all decision problems which can be solved using polynomial space), introducing new ideas for providing fast parallel algorithms for specific semi-definite programmes
  • Developed a fast parallel algorithm for positive semi-definite programmes that is heavily used in optimisation, approximation and complexity theory
  • Pursues a multi-disciplinary approach by collaborating extensively with scientists and physicians from research institutions, pharmaceutical companies and academia from across Singapore and around the world
  • Over 37 papers published in international journals, with 20 in premium tier ones such as Science, Nature Medicine, Immunity, Blood, Proceedings of the National Academy of Sciences, and over 900 citations received
  • Has a current Hirsch index of 16, signifying high scientific productivity and impact
  • Authored three manuscripts included in Faculty of 1000 and two covering articles on the BBC
  • Internationally recognised as a leading researcher in the field of immunology
  • Reviewer for leading international Journalrnals, such as Blood, Journal of Immunology and FEBS (Federation of European Biochemical Societies) Letters
  • Co-founder and non-executive director of the British Stem Cell Registry Ltd
  • Founding member and Meetings secretary, Singaporean Society for Immunology
  • Excellence in Research, Yong Loo Lin School of Medicine, NUS (2007)
  • Office of Life Sciences Young Investigator Award, NUS (2005)
  • First prize for Best Research Presentation, Cambridge Institute for Medical Research (2003)
"To build one of the world's best antibody-based laboratories for translating antibody candidates into new diagnostics and therapeutics, and to launch a spin-off company from NUS that will lead the way in antibody-based products focussed on Asian disease phenotypes."